Development of a quality indicator set for the optimal acute management of moderate to severe traumatic brain injury in the Australian context

Toby Jeffcote, Camila R. Battistuzzo, Rebecca Roach, Catherine Bell, Cino Bendinelli, Stephen Rashford, Ron Jithoo, Belinda J. Gabbe, Oliver Flower, Gerard O’Reilly, Lewis Campbell, D. James Cooper, Zsolt J. Balogh, Andrew U UdyResearch Square 2024 · DOI

Introduction

Moderate to severe traumatic brain injury (msTBI) represents a significant public health challenge in Australia, with an estimated annual economic impact of A$2 billion. While clinical guidelines for management exist, the actual delivery of care remains heterogeneous across different hospitals and regions. Previous international benchmarking efforts, such as the European CENTER-TBI study, focused heavily on structural indicators—such as the presence of 24-hour imaging facilities. However, in the Australian context, where major trauma centers are relatively uniform in infrastructure, the critical variance lies in clinical processes and logistical efficiency.

This study aimed to develop a localized, consensus-based set of quality indicators (QIs) to measure structure, process, and outcome factors. These indicators serve as the foundation for the PRECISION-TBI program, a prospective cohort study designed to identify and promote optimal clinical management of msTBI across Australia.

Methods

The researchers utilized a structured Delphi process to reach a reliable consensus among a multidisciplinary panel of experts. The development progressed through three distinct phases:

  1. Preliminary Development: A steering committee of four clinicians and researchers drafted an initial list of 45 indicators based on a review of existing literature, including the Brain Trauma Foundation guidelines and the IMPACT prognostic model.
  2. Advisory Committee Refinement: A group of ten senior experts, including neurosurgeons, intensivists, and trauma nurses, refined the initial set. They adjusted terminology and ensured comprehensive coverage across the entire care pathway, from pre-hospital arrival to rehabilitation.
  3. Delphi Panel Assessment: A larger panel of 44 experts (median 15 years of experience) participated in two rounds of voting. Each indicator was rated on a 5-point Likert scale across four dimensions: Validity (relationship to patient outcomes), Measurement Feasibility, Variability (current practice differences), and Action Feasibility. Inclusion in the final set required meeting strict statistical thresholds for agreement.

Results

The Delphi process resulted in a final set of 32 quality indicators categorized into five domains reflecting the msTBI care pathway:

  • Pre-hospital (5 indicators): Focused on minimizing secondary insults, including targets for time to hospital arrival (< 127 minutes) and the avoidance of hypoxia and hypotension during transport.
  • Emergency Department (5 indicators): Emphasized logistical speed, such as ensuring head CT scans are performed within 60 minutes of admission for 90% of patients.
  • Surgical Phase (4 indicators): Addressed resource availability and protocol adherence, including 24/7 operating room access and standardized management of intracranial hematomas.
  • Intensive Care (16 indicators): The largest category, reflecting the complexity of acute management. Indicators focused on physiological thresholds (ICP/CPP monitoring), fluid balance, and venous thromboembolism (VTE) prophylaxis.
  • Follow-up and Outcome (2 indicators): Included access to specialist rehabilitation and the use of observed versus predicted neurological outcomes based on IMPACT scores.

Discussion

A key finding of this study is the shift from structural to process-oriented indicators. In a mature healthcare system like Australia's, the "quality" of care is better measured by the efficiency of resource use (e.g., time to CT) rather than the mere presence of equipment.

The study also highlighted a potential "acute care blind spot." The Delphi panel, largely composed of acute care clinicians, rejected several proposed rehabilitation and long-term follow-up indicators. This suggests a disconnect in the care continuum where acute teams focus intensely on the first 72 hours of survival, potentially overlooking metrics that define long-term functional recovery.

Furthermore, the adoption of "observed vs. expected" outcome measures represents a sophisticated approach to benchmarking. By adjusting for initial injury severity using the IMPACT score, the framework allows for a fairer comparison of performance between centers that may treat different patient populations.

Conclusion

The development of these 32 quality indicators provides a standardized roadmap for improving msTBI care in Australia. By focusing on granular clinical thresholds and logistical timelines, the framework moves beyond basic infrastructure to address the nuances of high-stakes acute management. The PRECISION-TBI project is currently implementing these indicators across 10 neurotrauma centers to provide real-time feedback and drive systemic quality improvement.

Summary updated

Abstract

<title>Abstract</title> Background The aim of this study was to develop a consensus-based set of indicators of high-quality acute moderate to severe TBI (msTBI) clinical management that can be used to measure structure, process and outcome factors that are likely to influence patient outcomes. This is the first stage of the PRECISION-TBI program which is a prospective cohort study that aims to identify and promote optimal clinical management of msTBI in Australia. Methods A preliminary set of 45 quality indicators was developed based on available evidence. An advisory committee of established experts in the field refined the initial indicator set in terms of content coverage, proportional representation, contamination and supporting evidence. The refined indicator set was then distributed to a wider Delphi panel for assessment of each indicator in terms of validity, measurement feasibility, variability and action feasibility. Inclusion in the final indicator set was contingent on pre-specified inclusion scoring. Results The indicator set was structured according to the care pathway of msTBI and included pre-hospital, emergency department, neurosurgical, intensive care, and rehabilitation indicators. Measurement domains included structure indicators, logistic indicators and clinical management indicators. The Delphi panel consisted of 44 participants (84% physician, 12% nursing, 4% primary research) with a median of 15 years of practice. Of the 47 indicators included in the second round of the Delphi, 32 indicators were approved by the Delphi group. Conclusion This study identified a set of 32 quality indicators that can be used to structure data collection to drive quality improvement in the clinical management of msTBI. They will also be used to guide feedback to PRECISION-TBI’s participating sites.
BibTeX
@inproceedings{jeffcote2024development,
  author = {Toby Jeffcote and Camila R. Battistuzzo and Rebecca Roach and Catherine Bell and Cino Bendinelli and Stephen Rashford and Ron Jithoo and Belinda J. Gabbe and Oliver Flower and Gerard O’Reilly and Lewis Campbell and D. James Cooper and Zsolt J. Balogh and Andrew U Udy},
  title = {{Development of a quality indicator set for the optimal acute management of moderate to severe traumatic brain injury in the Australian context}},
  booktitle = {Research Square},
  year = {2024},
  doi = {10.21203/rs.3.rs-4608646/v1},
}
Figure